Post-Operative Pain, Total Knee Arthroplasty
Conditions
Brief summary
The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that will involve a 1:1 randomization to total knee arthroplasty +/- cryoablation.
Interventions
Administered as part of patient standard of care.
Cryoablation will be administered on the leg of the knee indicated for surgery.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients are candidates for elective primary total knee arthroplasty for a diagnosis of osteoarthritis or inflammatory arthritis. * Patients have been medically cleared and scheduled for surgery
Exclusion criteria
* Patients with cold-related conditions (cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, and Raynaud's disease) * Surgery for fracture, infection, or malignancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Opioid Consumption during Post-Procedural Follow-Up Period | Month 3 Post-Operation (Approximately Week 8-9) | Measured as morphine milligram equivalents. |
| Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR.) Score | Month 3 Post-Operation (Approximately Week 8-9) | KOOS, JR. is a 7-item assessment of how participants feel about their knee and how well they are able to do usual activities. Each item is rated on a Likert scale; the raw score is the sum of item responses. The raw score is transformed into a total score ranging from 0-100, where 0 indicates total knee disability and 100 represents perfect knee health. |
Countries
United States
Contacts
NYU Langone Health